Pierre Arsène

Pierre Arsène has a long and varied work experience. In 2005, they were a Board of Students - General Secretary for the Bureau Des Eleves HEC Paris. The following year, they were an Intern for J.P. Morgan. In 2007, they were an Intern - Business Development Associate for Moleac. From 2008 to 2014, they held various positions at J.P. Morgan, including Analyst/Associate, Analyst, and Senior Associate. In 2012, they were an Associate for Lazard. Finally, in 2017, they became the Founder & CEO of Mursla, a multi-omics exosome characterisation company based in Cambridge. Pierre's current work focuses on second generation liquid biopsy tests to help with the screening of 90% of cancers that are still unscreened today, with a particular focus on liver cancer surveillance.

Pierre Arsène completed a Master of Science from HEC Paris in 2008. Prior to this, they studied Mathematics at Saint Jean de Douai from 2004. In 2017, they became a Visiting Researcher in Biophysics at the University of Cambridge.